About CAPTIS DIAGNOSTICS INC.
Captis Diagnostics develops innovative extracellular vesicle (EV) isolation technology for cancer research and diagnosis, offering high-efficiency isolation and diagnostic assays for early detection and treatment monitoring.
Extracellular vesicle (EV) isolation with over 90% efficiency in plasmaDevelopment of diagnostic assays for EV cargo analysisNanotechnology-based lipid nanoprobe for EV enrichmentSimple workflow for EV isolation in 15 minutesHigh stability with shelf-life over 8 monthsDownstream molecular analysis of EVsResearch support for academic and commercial diagnostic labsEarly cancer screening, diagnosis, and treatment response monitoring
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CAPTIS DIAGNOSTICS - SBIR CONCEPT AWARD - DEVELOPMENT OF NON-INVASIVE ASSAY FOR MOLECULAR CHARACTERIZATION OF | Department of Health and Human Services | $355K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CAPTIS DIAGNOSTICS INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.